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In-gel alkylationAbstract Mass spectrometry has been widely used, particularly in pharmacokinetic investigations
and for therapeutic drug monitoring purposes. Like any other analytical method some difﬁculties
exist in employing mass spectrometry, mainly when it is used to test biological samples, such as
to detect drug candidates in mammalian serum, which is rich in proteins, lipids and other contents
that may interfere with the investigational drug. The complexity of the serum proteome presents
challenges for efﬁcient sample preparation and adequate sensitivity for mass spectrometry analysis
of drugs. Enrichment procedures prior to the drug analysis are often needed and as a result, the
study of serum or plasma components usually demands either methods of puriﬁcation or depletion
of one or more. Selection of the best combination of sample introduction method is a crucial deter-
minant of the sensitivity and accuracy of mass spectrometry. The aim of this study was to determine
the highest serum protein precipitation activity of ﬁve commonly used sample preparation methods
and test their suitability for mass spectrometry. We spiked three small molecules into rabbit serum
690 T.M. Alshammari et al.and applied different protein precipitation methods to determine their precipitation activity and
applicability as a mass spectrometry introductory tool.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Plasma is frequently used as a biological matrix as it is easy
to collect (Olsen et al., 2004; Sjoholm et al., 1979).
Typically, it is widely used in studies of analytical method
development and validation, just prior to the animal trials.
Indeed, appropriate sample preparation is essential for
obtaining reliable and meaningful results. Consequently,
sample preparation is still an area of high importance when
a liquid chromatography and mass spectrometry (LC/MS/
MS) method is developed to assay biological samples (Xu
et al., 2005). It is predominantly used in the ‘optimisation’
of a sample for analysis with mass spectrometry (MS) tech-
niques. The importance of sample preparation is to ensure
that the analytical method maintains certain essential ele-
ments of robustness and consistency that are expected in
any bioanalytical assay (Xu et al., 2005).
Generally, the two main sample preparation methods used
for the MS analysis of blood, serum plasma and urine samples
are liquid–liquid extraction or solid-phase extraction (SPE)
(Bouzas et al., 2009). However, for drug discovery and
pharmacokinetics, protein precipitation (PP)/extraction is the
most common sample preparation procedure, which is the sim-
plest approach that requires minimal method development and
removes the majority of the protein from the sample (Xu et al.,
2005). PP with miscible organic solvents (usually acetonitrile
or methanol) is the most commonly used sample preparation
method because of its low cost and minimal method develop-
ment requirements (Ma et al., 2008). While, there are many PP
solvents that are widely used including organic and inorganic
solvents (Bouzas et al., 2009; Lawson, 1989), the selection pre-
dominantly depends on the investigational compound used.
Usually, the use of methanol is especially valuable for support
of preclinical pharmacokinetic studies conducted during the
lead optimisation stages of drug discovery, where rapid devel-
opment of assays for new compounds is essential (Henry et al.,
2013; Ma et al., 2008). In an attempt to investigate the suitabil-
ity of each of the solvents used for MS analysis of small
molecules in pharmacokinetics studies, we performed PP using
ﬁve different solvent systems and compared their ability to pre-
cipitate serum proteins and extract potential drug molecules
for MS analysis.2. Materials and methods
2.1. Serum samples
Blood was collected from a healthy rabbit housed at the Small
Animal Facility of the CSIRO Australian Animal Health
Laboratory. Serum was obtained by allowing the blood to clot
at room temperature for 2 h. The clotted blood was then
centrifuged for 10 min at 12,000g. Serum was then collected
and stored at 20 C.2.2. Conﬁrmation of compounds identity and purity using MS
Three potential antiviral compounds of small molecular weight
(pending patent) were selected for this study and given differ-
ent codes (AAHL 13, AAHL 18 and AAHL 42). The com-
pounds were initially dissolved in methanol at a
concentration of 0.5 mg/ml, then diluted in 50% methanol/
0.2% formic acid to a ﬁnal concentration of 10 lg/ml.
Diluted samples were analysed by direct infusion at a rate of
10 ll/min into the electrospray ionisation source of an LCQ
ion-trap mass spectrometer (Thermo, San Jose, CA, USA).
Spectra were acquired and averaged over 50 consecutive scans.
Full scans were acquired over the mass range m/z 50–500 to
give an indication of sample purity. High resolution zoom
scans were also performed that allowed determination of the
mass/charge state of the selected ion and hence an accurate
mass measurement of the selected ion.
2.3. Detection of compounds in rabbit serum
Rabbit serum was spiked with three investigational com-
pounds (AAHL 13, AAHL 18 or AAHL 42) at a concentra-
tion of 0.5 mg/ml. The spiked serum then underwent protein
precipitation using the described methods. The supernatants
from each treatment were collected and diluted 1:1 with
0.4% v/v formic acid to give a ﬁnal solvent composition of
50% methanol/0.2% formic acid and analysed by MS.
2.4. Methanol extraction method
Brieﬂy, 100 ll of serum was mixed with 900 ll of HPLC-grade
methanol. Following centrifugation, aliquots of 100 ll of the
supernatants were dried and then resuspended in electrophore-
sis sample buffer (MES) and analysed by electrophoresis, or
aliquots were diluted in 50% methanol/0.2% formic acid for
MS analysis.
2.5. Folch extraction method
A mixture of chloroform–methanol in the ratio of 2:1 by vol-
ume was prepared and 400 ll of this mixture was added to a
100 ll of serum. The upper phase of each sample was used
for analysis, because the proteins were precipitated in the mid-
dle and lower phases.
2.6. Acetone extraction method
Brieﬂy, 900 ll of acetone was added to 100 ll of serum. The
supernatant only was used for analysis. For electrophoresis,
samples were dried and then resuspended in sample buffer
(MES) and for MS analysis samples were diluted in 50%
methanol/0.2% formic acid.
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A volume of 100 ll of serum was mixed with a volume of
300 ll of acetonitrile. The sample was centrifuged and super-
natant of the mixture was collected and then analysed.
2.8. Proteinase K protein depletion method
The Proteinase K method was performed as per manufac-
turer’s recommendation. Brieﬂy, serum samples were treated
with 200 lg/ml of proteinase K for 18 h at 37 C. In order to
determine the most effective concentration of proteinase K, a
number of different concentrations and incubation periods
were trailed. The most effective concentrations were then used
and compared to other extraction methods. Proteinase K trea-
ted samples were centrifuged and supernatants were collected
for analysis.
2.9. Conﬁrmation of protein precipitation by electrophoresis
Supernatants from protein precipitated serum samples from
different extraction methods were obtained after cen-
trifugation of treated samples that pelleted the precipitated
proteins. Supernatants were then dried in a centrifugal vacuum
concentrator (Savant Speedvac, Thermo). Dried samples were
then diluted 1:100 in electrophoresis sample buffer. The diluted
samples were then separated by SDS–PAGE and proteins were
visualised by Coomassie blue or silver staining.
2.10. In-gel alkylation and digestion of proteins
Brieﬂy, the Coomassie blue stained bands were cut from the
SDS–PAGE gel, reduced and alkylated, in-gel digested using
trypsin, extracted and analysed using LC–MS/MS to
determine their identity.3. Results
3.1. Conﬁrmation of compounds identity and purity
The identity and purity of each of the three compounds
(Fig. 1a–f) were conﬁrmed against the given masses (Table 1).
Of note, a number of small peaks are shown in all the spectra
(Fig. 1a–f), which represent the background readings of each
sample. Thus, the zoomed spectra provide more accurate read-
ings of the dominant peaks that can be used to conﬁrm the iden-
tity and estimate the purity of the investigational compound. A
noticeable peak at mass 320 is evident in the spectra of AAHL
42 and AAHL 18 (Fig. 1a and e, respectively). While the source
of this peak is unknown, it is well known that precipitated
serum samples contain high concentrations of salts (Huang
et al., 2013; Cai et al., 2002); hence, it is possible that the 320
mass peak is one of the dominant salts present in the super-
natant. Importantly, the mass values presented by the peaks
are slightly different to those in Table 1. For instance the
detected peaks for AAHL 42 are at 318.1, AAHL 13 are at
333.1 and AAHL 18 are detected at 402.9, while their reported
values (Table 1) show AAHL 42 at 315.8, AAHL 13 at 332.36
and AAHL 18 at 402.16. The differences observed are due to
the fact that the values in Table 1 are molecular weight values(isotopic average mass that might include the less abundant
naturally occurring isotopes), which are the values used in the
periodical table of elements (Grueiro Noche et al., 2013;
Leigh et al., 1998) whereas, the peak values presented in the
spectra are of the monoisotopic mass spectrum (a spectrum
containing only ions made up of the principal isotopes of atoms
making up the original molecule) (Selvadurai and
Meyyanathan, 2011; McNaught and Wilkinson, 1997).
Monoisotopic mass is the mass of the abundance isotopes of
chemical elements as naturally found, which is also known as
naturally abundance isotopes (Leigh et al., 1998).
3.2. Comparison of different extraction methods
Different concentrations of proteinase K were used at different
incubation times to determine the optimal concentration to use
(see Fig. 2). Based on the current results we can conclude that
at 18 h of incubation a 200 lg/ml of proteinase K has digested
and removed most of the serum protein. After the determina-
tion of a suitable proteinase K concentration, a number of
known protein extraction methods were compared using elec-
trophoretic analysis.
All of the concentrations and treatments were carried out as
per manufacturer’s or literature recommendations. The results
indicated that most of the solvents used produced signiﬁcant
reduction in the serum proteins (Fig. 3a and b). Methanol, ace-
tone and acetonitrile extraction methods have almost com-
pletely removed all of the serum proteins. Based on the fact
that the methanol extraction method was effective as well as
the fact that investigational compounds are dissolved in
methanol, gave the methanol extraction method some advan-
tage over the other methods used.
3.3. Recovery of investigational compounds as assessed by MS
The MS analysis of samples from serum supernatants treated
with acetone, acetonitrile, chloroform–methanol and pro-
teinase K showed no recovery of any of the investigational
compounds. However, one out of three investigational com-
pounds from the methanol treated serum AAHL18 was
detected by MS (Fig. 4). The compound was detected mostly
as a sodiated adduct (M+ Na) at m/z 425 (also seen in
Fig. 1 e) with a minor amount of the non-sodiated at m/z 403.
The poor recovery of the other two compounds might be
due to a range of different reasons. The most likely biochem-
istry related reasons that might provide answers to this are
the instability of the investigational compounds (insentience
reaction) and the possibility of the presence of reactive serum
components remaining in the supernatant after PP, both of
which require further investigation.
3.4. Determination of investigational compounds disappearance
Potential reasons for the poor recovery of the investigational
compounds from serum were investigated. One possibility that
could explain the low recovery rate of the compounds is the
stability of these compounds, which was considered unlikely
based on the given data that their chemical structures appear
to be stable, these compounds were prepared almost a decade
ago and their chemical compositions were rechecked and con-
ﬁrmed repeatedly (data no shown). The second possibility may
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Figure 1 MS spectra of the 3 lead compounds. Electron ionisation mass spectrum of AAHL 42 (a) and a zoomed format of the spectrum
(b), represent the well resolved high peak of the expected mass of the hit compound at approximately 318. Figures (c) and (d) represent the
electron ionisation mass spectrum and its zoomed format for AAHL 13 respectively. The well-deﬁned high peaks of 333.1 presented in the
spectrum show the expected mass value of the hit compound. The spectrum for AAHL 18 hit compound is presented in ﬁgures (e) and (f)
with highest peak of 402.86 representing the mass number for this compound (refer to Table 1 for compound masses).
692 T.M. Alshammari et al.be the presence of reactive components in serum remaining
after methanol-based PP. Dried supernatants from methanol
extracted serum samples were reconstituted in different vol-
umes of MES buffer, analysed by electrophoresis and then
visualised by silver nitrate staining (Fig. 5). Unexpectedly,
the samples were shown to contain a number of unknown pro-
teins, which might, as speculated, have reacted with or modi-
ﬁed the compounds and prevented their recovery.3.5. Identiﬁcation of the proteins from rabbit serum by ‘in-gel’
protein alkylation and digestion
To determine the identity of the unknown proteins, four lanes
from each of the upper and lower bands from the Coomassie
blue stained gel were excised and treated as above and in-gel
protease digested with trypsin. Generally, the Coomassie blue
stain is less sensitive than the silver stain; thus, only the upper
(e) (f)
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Figure 1 (continued)
Table 1 Characterisation of the investigational compounds.
Compound ID Molecular weight HPLC purity (%) Method of conﬁrming compound identity
AAHL 42 315.8 98.8 ESI MS/
1
H NMRa
AAHL 13 323.36 99.8 ESI MS/
1
H NMR
AAHL 18 402.16 99.5 ESI MS/
1
H NMR
The table includes the identity, molecular weight, HPLC purity and method of conﬁrmation of purity.
a ESI MS= [electrospray ionisation mass spectrometry].
1
H NMR= [Hydrogen-1 nuclear magnetic resonance].
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Figure 2 SDS PAGE analysis of serum proteins following
treatment with different concentrations of proteinase K.
Electrophoretic analysis of rabbit serum treated with different
proteinase K concentrations. From left to right, ﬁrst lane has the
MW markers, lane 2 contains untreated serum diluted 1:200 in
running buffer, lanes 3, 4 and 5 are samples that were digested for
18 h with 100 lg/ml, 200 lg/ml 300 lg/ml of proteinase K,
respectively. While, lane 6 is empty, lanes 7 through to 10 contain
serum samples digested with the same concentration and order of
the previous lanes except these were treated for 1 h instead.
Comparison of different methods and their suitability 693bands and lower bands (62 and 12 kDa, respectively) were
stained by silver nitrate stain (Fig. 5). Hence, only these bands
were sent for LC–MS/MS analysis.
Analysis of the raw LC–MS/MS data for the trypsin-di-
gested unknown upper band (62 kDa) searched against the
NCBI non-redundant protein database revealed a match to
rabbit serum albumin. Thirteen peptides were identiﬁed that
met the cross-correlation search criteria (see in bold peptides
in Fig. 6) and these peptides represented 31% coverage of
the rabbit serum albumin sequence. No identiﬁcations were
obtained for the unknown trypsin digested lower band
(12 kDa) (see Fig. 7).
4. Discussion
Rapidity and reliability of the high throughput bioanalysis of
drug candidates in plasma samples are essential for
pharmacokinetics, pharmacodynamic and toxicokinetic stud-
ies (Bouzas et al., 2009; Ma et al., 2008). Mass spectrometry
analysis has become the technique of choice for analysis
(Grueiro Noche et al., 2013; Leigh et al., 1998) and it is the
most widely used bioanalytical method in the drug discovery
arena. The selected method is anticipated to be used to analyse
(a) Coomassie bluestained gel. (b) Silver stained gel.
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Figure 3 SDS PAGE comparison between supernatants from different extraction methods. Electrophoretic analysis of rabbit serum
precipitated by different protein precipitation methods. From left to right, ﬁrst lane contain MW markers, second and third lanes
represent serum (1:100 in running buffer) and pellet from methanol precipitated serum respectively, acetone precipitation method (lane 4),
chloroform–methanol method (lane 5). While lane 6 represents serum that was precipitated with 200 lg/ml proteinase K, and lane 7 and
lane 8 represent acetonitrile and methanol precipitated serum, respectively. Serum precipitated samples were dried and then reconstituted
in 100 ll MES, of which 15.6 ll were used per lane.
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Figure 4 Spectrum of the AAHL18 compound recovered from the supernatant of methanol treated serum. A mass spectrum of AAHL
18 compound recovered from spiked serum (a) and its zoomed format (b). The recovery rate is fairly low as compared to positive control
(Fig. 1e) with a number of other high peaks present in the spectrum. While the expected peak of 402 is almost missing, a high peak 425.0
represents the sodiated form of AAHL 18 compound.
694 T.M. Alshammari et al.the investigational compounds from serum samples. Therefore,
due to the complexity of the matrix, in most cases an extrac-
tion step for sample clean-up and pre-concentration, such asprotein precipitation, is required before analysis in order to
achieve the required sensitivity (Moreno-Bondi et al., 2009).
The importance of sample preparation for bioanalytical
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Figure 5 SDS–PAGE analysis of unprecipitated proteins from
methanol treated serum. Electrophoretic separation of proteins
derived from supernatant of methanol protein precipitated rabbit
serum. Lanes: (1) molecular weight markers lanes 2, 3, 4 and 5
dried supernatants reconstituted in 20, 40, 80 and 100 ll running
buffer, respectively. Total volumes of 20 ll per lane of each sample
were loaded (15.6 ll of reconstituted samples plus loading buffers
making a ﬁnal volume of 20 ll). Gels were stained with silver
nitrate.
Comparison of different methods and their suitability 695methods cannot be over emphasised. The sample preparation
step before the MS analysis is intended to facilitate the
determination of components of the drug candidate that
involve pharmacokinetics and metabolic stability (Huang
et al., 2013; Lee, 2002).
The current study describes the initial stage of pharmacoki-
netic analysis, namely analytical method validation using three1 MKWVTFISLL FLFSSAYSRG VFRREAHKSE
61 EEHAKLVKEV TDLAKACVAD ESAANCDKSL
121 ERNECFLHHK DDKPDLPPFA RPEADVLCKA
181 YAQKYKAILT ECCEAADKGA CLTPKLDALE
241 VRLSQRFPKA DFTDISKIVT DLTKVHKECC
301 ECCDKPILEK AHCIYGLHND ETPAGLPAVA
361 RHPDYSVVLL LRLGKAYEAT LKKCCATDDP
421 QLGDYNFQNA LLVRYTKKVP QVSTPTLVEI
481 LNRLCVLHEK TPVSEKVTKC CSESLVDRRP
541 PETERKIKKQ TALVELVKHK PHATNDQLKT
601 ESSKATLG
Figure 6 Sequence of rabbit serum albumin. Enbolded sequences
compared to that of NCBI non-redundant protein databases, of which
albumin.investigational compounds (AAHL 13, AAHL 18 and AAHL
42). The analytical method for drug detection is a signiﬁcant
determinant factor in the conduct of any animal study. The
primary objective of pharmacokinetic study is to determine
the fate of an investigational compound following its
administration to an experimental animal. This can only be
achieved by the use of reliable analytical methods that can
provide reliable and interpretable results. It is deemed unac-
ceptable to conduct animal experimentation without the use
of reliable and sensitive analytical methods. The objective of
this study was to validate a sample preparation method for
mass spectrometry analysis for pharmacokinetic studies.
Accordingly, the precipitation abilities of ﬁve different protein
extraction methods were compared using electrophoresis
analysis. Plasma sample preparation is a key consideration in
detection system reliability (Li et al., 2012; Ma et al., 2008).
The comparison between the protein extraction abilities of
each of the different methods showed signiﬁcant differences
among the tested methods with the methanol precipitation
method being shown to have precipitated most of the serum
proteins (Fig. 3a and b). The solubility of investigational com-
pounds is an important factor in method selection, and in this
study the investigational compounds are methanol soluble;
hence, methanol was selected as the most suitable serum pre-
cipitation method. Surprisingly, an extremely low recovery
rate of the investigational compounds was observed in the
methanol extracts. Following the failure to detect the
investigational compounds from serum samples, other meth-
ods were then separately used to investigate whether the com-
pound loss was methanol related. At this stage, the magnitude
of the differences between the serum precipitation abilities
observed earlier appeared to be unimportant. The detection
rate of the investigational compounds using the other extrac-
tion methods remained low, suggesting that the inability of
detecting the investigational compounds in serum samples
might not be related to sample preparation methods used. In
order to test this theory, supernatants from methanol
precipitated serum samples were spiked with the investiga-
tional compounds. The MS analysis of the spiked supernatants
only showed a low detection rate of one of the three tested
compounds (AAHL 18) (Fig. 4), which was signiﬁcantly below
the detection limit. The low detection rate suggests the
presence of serum component(s) in the supernatant, which IAHRFNDVGE EHFIGLVLIT FSQYLQKCPY
HDIFGDKICA LPSLRDTYGD VADCCEKKEP
 FHDDEKAFFG HYLYEVARRH PYFYAPELLY
 GKSLISAAQE RLRCASIQKF GDRAYKAWAL
 HGDLLECADD RADLAKYMCE HQETISSHLK
EEFVEDKDVC KNYEEAKDLF LGKFLYEYSR
 HACYAKVLDE FQPLVDEPKN LVKQNCELYE
SRSLGKVGSK CCKHPEAERL PCVEDYLSVV
 CFSALGPDET YVPKEFNAET FTFHADICTL
VVGEFTALLD KCCSAEDKEA CFAVEGPKLV
represent peptides identiﬁed by MS analysis. The results were
thirteen peptides from the 62 kDa protein matched rabbit serum
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Figure 7 Mass spectrometry analysis of unprecipitated protein. Mass spectrometry analysis of the 62 kDa (a) and 12 kDa (b)
proteins from methanol precipitated serum. Bands were cut from the gel and then undergone in gel protein alkylation and digestion.
Digested proteins were then analysed by LC/MS/MS.
696 T.M. Alshammari et al.might be interfering with the investigational compounds.
Interestingly, Coomassie blue and silver stain analysis of the
supernatant from methanol precipitated serum, clearly showed
two protein bands (Fig. 5). The LC–MS/MS analysis of these
bands revealed that the upper band (67 kDa) is albumin, but
the lower band (12 kDa) did not match any of the databases.
It is therefore, possible that the detected proteins might have
interfered with the investigational compounds. For instance,
albumin is the most abundant protein in blood plasma
(Zammataro et al., 2011; Olsen et al., 2004) and has a high
drug binding afﬁnity (Wang et al., 2012; Sjoholm et al.,
1979). Other unprecipitated proteins could have also affected
the compounds. Theoretically, supernatant from precipitated
serum samples is protein free, but in actual fact, at least
10% of serum proteins, mostly less than 20 kDa remain
unprecipitated (Alpert and Shukla, 2003). The possibility of
serum protein interference with the investigational compounds
could potentially be conﬁrmed by the use of rabbit serum
dialysis; however, such conﬁrmation would not have made a
substantial contribution to their recovery by MS.
The inability to detect the compounds from serum samples
might be due to multiple factors, one of which is the interfer-
ence of serum components. It is possible that these components
degraded or instantaneously adsorbed the spiked compounds.It might also be possible that the investigational compounds
were precipitated with serum proteins. While the precipitates
were not analysed, the failure to detect the compounds after
spiking the supernatants from methanol extracted serum,
which supposedly does not contain any proteins, ruled out
the co-precipitation possibility. This has also ruled out the
possibility of instant metabolism of the compounds by serum
components. Despite the fact that these compounds were indi-
cated to be relatively chemically stable, their stability in serum
was not determined and thus, compound instability in serum
might well be a possible factor that contributed to the low
recovery rate. Of note, the compounds were shown to be stable
in methanol both at room temperature and at 4 C where they
were stored for months. Thus, methanol would not be consid-
ered as a possible factor for the low recovery. The low detection
of these compounds from serum could perhaps be a result of a
combination of reasons that lead to small residual quantities
that are not detectable by MS. However, the exact mechanism
of how these compounds were lost is still unclear and unless
determined, the possibilities would merely be speculations.
Sample preparation is an important part of MS for serum
sample analyses. There seem to be signiﬁcant differences
between the protein precipitation ability of the ﬁve tested
methods, with methanol extraction showed to have the highest
Comparison of different methods and their suitability 697precipitation activity amongst all. The inability of completely
precipitating all serum proteins warrants further investigation
into possible method modiﬁcation to possibly enhance protein
precipitation activity.
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